Fingerprint
Dive into the research topics of 'Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Dose-dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial
Claire Baker, Suman Wason, Phillip Banks, Sangeeta Sawhney, Anna Chang, Thomas Danne, Diane Gesty-Palmer, Jake A. Kushner, Darren K. McGuire, Frank Mikell, Mark O'Neill, Anne L. Peters, Paul Strumph
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations